The Degree of Programmed Death-Ligand 1 (PD-L1) Positivity as a Determinant of Outcomes in Metastatic Triple-Negative Breast Cancer Treated With First-Line Immune Checkpoint Inhibitors

In metastatic triple-negative breast cancer (TNBC), the efficacy of immune checkpoint inhibitors (ICIs) in combination with chemotherapy has been demonstrated in randomized clinical trials (RCTs). Despite this, an indirect comparison is not yet available. Reconstruction of individual patient data fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Spazio, Lorenzo, Rivano, Melania, Cancanelli, Luca, Chiumente, Marco, Mengato, Daniele, Messori, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743568/
https://www.ncbi.nlm.nih.gov/pubmed/35028245
http://dx.doi.org/10.7759/cureus.21065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743568/
https://www.ncbi.nlm.nih.gov/pubmed/35028245
http://dx.doi.org/10.7759/cureus.21065

Ejemplares similares